PDF
File
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
"Our profitable growth continues in the third quarter with net sales growing over 5% organically and a nearly 35% increase in adjusted EBIT. We have also reached several important milestones in the commercialization of the new SEM Scanner in the quarter, including a contract with one of the largest GPOs in the US," says Joacim Lindoff, President & CEO. "We enter the year's final quarter with a high activity level and well-filled order books, and look forward to delivering a strong finish to 2021," adds Joacim Lindoff.
July-September 2021 in brief- Net sales increased to SEK 2,247 M (2,143).
- Adjusted EBITDA increased 16.8% to SEK 524 M (448).
- Adjusted operating profit increased by 34.6% to SEK 280 M (208).
- Profit after financial items increased to SEK 252 M (176).
- Earnings per share rose to SEK 0.69 (0.49).
- Cash flow from operations amounted to SEK 390 M (525).
Telephone conference
Fund managers, analysts and the media are invited to a teleconference on October 28 at 08.00 CEST. Please see details below to join the conference:
Sweden: +46 8 505 583 52
USA: +1 646 722 4903
UK: +44 333 300 9032
A presentation will be held during the telephone conference. To access the presentation, please use this link: https://tv.streamfabriken.com/arjo-q3-2021
Alternatively, use the following link to download the presentation:
https://www.arjo.com/int/about-us/investors/reports--presentations/2021/
A recording of the teleconference will be available for 90 days via the following link:
https://tv.streamfabriken.com/arjo-q3-2021
For more information, please contact:
Kornelia Rasmussen
Executive Vice President, Marketing Communications & Public Relations
Tel: +46 (0)10 335 4810
Email: kornelia.rasmussen@arjo.com
Maria Nilsson
Investor Relations & Corporate Communications
Tel: +46 (0)10 335 4866
Email: maria.nilsson@arjo.com
This information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CEST on October 28, 2021.
About Arjo
At Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With over 6,000 people worldwide and 60 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com